These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16821341)

  • 1. [Case-control study of the genes of receptors of the androgens of vitamin-D and of 5-alphareductase in a population of Afro-Caribbean population with prostate cancer].
    Veronique-Baudin J; Dieye M; Kouyoumdjian JC; Vacheron F; Draganescu C; Azaloux H
    Prog Urol; 2006 Jun; 16(3):303-10. PubMed ID: 16821341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer].
    Liu JH; Li HW; Tong M; Li M; Na YQ
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):364-8. PubMed ID: 15061984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
    Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
    Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
    Andersson P; Varenhorst E; Söderkvist P
    Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
    Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.
    Schatzl G; Madersbacher S; Gsur A; Preyer M; Haidinger G; Haitel A; Vutuc C; Micksche M; Marberger M
    Prostate; 2002 Jul; 52(2):130-8. PubMed ID: 12111704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
    Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C
    J Hum Genet; 2002; 47(8):413-8. PubMed ID: 12181642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
    Lindström S; Wiklund F; Adami HO; Bälter KA; Adolfsson J; Grönberg H
    Cancer Res; 2006 Nov; 66(22):11077-83. PubMed ID: 17108148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
    Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor polymorphisms and lethal prostate cancer.
    Kibel AS; Isaacs SD; Isaacs WB; Bova GS
    J Urol; 1998 Oct; 160(4):1405-9. PubMed ID: 9751364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
    Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
    Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer.
    Lange EM; Chen H; Brierley K; Livermore H; Wojno KJ; Langefeld CD; Lange K; Cooney KA
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):439-42. PubMed ID: 10794490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
    Modugno F; Weissfeld JL; Trump DL; Zmuda JM; Shea P; Cauley JA; Ferrell RE
    Clin Cancer Res; 2001 Oct; 7(10):3092-6. PubMed ID: 11595700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The androgen receptor gene GGN microsatellite and prostate cancer risk.
    Platz EA; Giovannucci E; Dahl DM; Krithivas K; Hennekens CH; Brown M; Stampfer MJ; Kantoff PW
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):379-84. PubMed ID: 9610786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
    Hayes VM; Severi G; Eggleton SA; Padilla EJ; Southey MC; Sutherland RL; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):993-6. PubMed ID: 15824176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population.
    Giwercman YL; Abrahamsson PA; Giwercman A; Gadaleanu V; Ahlgren G
    Eur Urol; 2005 Oct; 48(4):679-85. PubMed ID: 16039774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.
    Ntais C; Polycarpou A; Ioannidis JP
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1395-402. PubMed ID: 14693728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.